5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9346 | CVN424 | GPR | |
CVN424 is a selective and novel GPR6 Inverse agonist effective in models of Parkinson Disease. | |||
T82263 | GPR61 Inverse agonist 1 | ||
Compound 1, identified as a GPR61 inverse agonist, exhibits an IC50 of 11 nM, rendering it suitable for metabolism and body weight disorder research, including obesity and cachexia [1]. | |||
T80892 | UR-MB-355 | ||
UR-MB-355, a GPR3 ligand, exhibits submicromolar affinities for its primary target GPR3 as well as the closely related receptors GPR6 and GPR12 [1]. | |||
T39218 | (S)-CVN424 | (S)-CVN424 | |
(S)-CVN424 is a powerful modulator of G-Protein-Coupled Receptor 6 (GPR6), known for its involvement in neurological and psychiatric disorders research, such as Parkinson's disease. | |||
T21500 | Sphingosine-1-phosphate | S1P | Endogenous Metabolite , S1P Receptor , LPL Receptor |
Sphingosine-1-phosphate (S1P) is an agonist for S1P1-5 receptors and a ligand for GPR3, GPR6, GPR12.Sphingosine-1-phosphate is an intracellular second messenger that mobilises Ca2+ as an extracellular ligand for G-protei... |